LCM
ABMD

Laurion Capital Management’s Abiomed Inc ABMD Stock Holding History

Laurion Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,519
Closed -$1.86M – 1258
2019
Q1 		$1.86M Sell
6,519
-17,403
-73% -$5.78M 0.03% 341
2018
Q4 		$7.78M Buy
+23,922
New +$8.31M 0.14% 199
2017
Q1 		– Sell
-2,140
Closed -$241K – 1635
2016
Q4 		$241K Buy
+2,140
New +$248K ﹤0.01% 969
2016
Q3 		– Sell
-88,540
Closed -$9.68M – 1148
2016
Q2 		$9.68M Buy
+88,540
New +$8.81M 0.15% 160

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Laurion Capital Management's ABMD Position: Q2 2019 in Review

Laurion Capital Management sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 6,519 shares — an estimated $1.86M sold.

Laurion Capital Management first reported a position in ABMD in Q2 2016 and held it in 4 quarters. The position peaked at $9.68M in Q2 2016. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Laurion Capital Management reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Laurion Capital Management sold 6,519 Abiomed Inc shares in Q2 2019, an estimated $1.86M.
  • Laurion Capital Management first reported a position in Abiomed Inc in Q2 2016 and held it in 4 quarters.
  • Laurion Capital Management's Abiomed Inc position peaked at $9.68M in Q2 2016.
  • 483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Laurion Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.